Title : Activity of sunitinib in patients with advanced neuroendocrine tumors.

Pub. Date : 2008 Jul 10

PMID : 18612155






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sunitinib malate, an oral tyrosine kinase inhibitor, has activity against VEGFRs as well as platelet-derived growth factor receptors, stem-cell factor receptor, glial cell line-derived neurotrophic factor, and FMS-like tyrosine kinase-3. Sunitinib fms related receptor tyrosine kinase 3 Homo sapiens